Bookbuilding IPO | ₹126 Cr | Listed at BSE, NSE | Mon, Sep 1, 2025 - Wed, Sep 3, 2025
Amanta Healthcare IPO is a book build issue of ₹126.00 crores. The issue is entirely a fresh issue of 1.00 crore shares of ₹126.00 crore.
Amanta Healthcare IPO bidding started from Sep 1, 2025 and ended on Sep 3, 2025. The allotment for Amanta Healthcare IPO was finalized on Sep 4, 2025. The shares got listed on BSE, NSE on Sep 9, 2025.
Amanta Healthcare IPO price band is set at ₹126 per share. The lot size for an application is 119. The minimum amount of investment required by an retail is ₹14,994 (119 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,666 shares), amounting to ₹2,09,916, and for bNII, it is 67 lots (7,973 shares), amounting to ₹10,04,598.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Amanta Healthcare IPO RHP for detailed Information.
IPO Open
Mon, Sep 1, 2025
IPO Close
Wed, Sep 3, 2025
Issue Price
₹126 per share
Market Cap (Pre-IPO)
₹489.25 Cr
| IPO Date | 1 to 3 Sep, 2025 |
| Listed on | Tue, Sep 9, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹120 to ₹126 |
| Issue Price | ₹126 per share |
| Lot Size | 119 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,00,00,000 shares (agg. up to ₹126 Cr) |
| Fresh Issue | 1,00,00,000 shares (agg. up to ₹126 Cr) |
| Share Holding Pre Issue | 2,88,29,351 shares |
| Share Holding Post Issue | 3,88,29,351 shares |
| BSE Script Code / NSE Symbol | 544502 / AMANTA |
| ISIN | INE084K01015 |
Amanta Healthcare IPO offers total 1,00,00,000 shares. Out of which 50,00,000 (50.00%) allocated to QIB, 20,00,000 (20.00%) allocated to QIB (Ex- Anchor), 15,00,000 (15.00%) allocated to NII 35,00,000 (35.00%) allocated to RII and 30,00,000 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 50,00,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 30,00,000 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 20,00,000 (20.00%) | NA |
| NII (HNI) Shares Offered | 15,00,000 (15.00%) | NA |
| − bNII > ₹10L | 10,00,000 (10.00%) | 600 |
| − sNII < ₹10L | 5,00,000 (5.00%) | 300 |
| Retail Shares Offered | 35,00,000 (35.00%) | 29,411 |
| Total Shares Offered | 1,00,00,000 (100.00%) |
Investors can bid for a minimum of 119 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Amanta Healthcare IPO raises ₹37.80 crore from anchor investors. Amanta Healthcare IPO Anchor bid date is August 29, 2025.
📝 Anchor Investors Letter (PDF)
| Bid Date | Fri, Aug 29, 2025 |
| Shares Offered | 30,00,000 |
| Anchor Portion (₹ Cr.) | 37.80 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, Oct 3, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Dec 2, 2025 |
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
Experienced management team supported by a large, diverse and skilled workforce.
Amanta Healthcare Ltd.'s revenue decreased by 2% and profit after tax (PAT) rose by 189% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | 70.00 |
| 2 | Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | 30.13 |
| 3 | General corporate purposes | 6.60 |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
| Promoter Holding | 85.6% | 63.56% |
| Market Cap | ₹489.25 Cr. |
The Amanta Healthcare IPO is subscribed 82.60 times on September 3, 2025 5:04:33 PM (Day 3). The public issue subscribed 54.96 times in the retail category, 35.86 times in the QIB category, and 209.40 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB (Ex Anchor) | 35.86 | 20,00,000 | 7,17,22,490 |
| NII | 209.40 | 15,00,000 | 31,41,06,093 |
| bNII (bids above ₹10L) | 226.13 | 10,00,000 | 22,61,27,251 |
| sNII (bids below ₹10L) | 175.96 | 5,00,000 | 8,79,78,842 |
| Retail | 54.96 | 35,00,000 | 19,23,55,051 |
| Total | 82.60 | 70,00,000 | 57,81,83,634 |
Total Application : 13,90,775
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Manager’s fees and commissions (including brokerage and selling commission) | 11.08 |
| 2 | Underwriting commission | 1.60 |
| 3 | Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Issue. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 0.68 |
| 4 | Fees payable to the Registrar to the Issue | 0.18 |
| 5 | Fees payable to other parties, including but not limited to professional service provider, industry service provider and Monitoring Agency | 0.30 |
| 6 | Statutory Auditors, for issuing auditors report on Restated Financial Information | 1.13 |
| 7 | Independent Chartered Accountant, to verify the details and provide certifications with respect to certain information included in the DRHP/RHP/Prospectus | 0.23 |
| 8 | Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 1.91 |
| 9 | Printing and distribution of issue stationery | 0.10 |
| 10 | Advertising and marketing expenses | 1.25 |
| 11 | Fees payable to legal counsel | 0.80 |
| 12 | Miscellaneous |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹126.00 | ₹126.00 |
| Open | ₹134.00 | ₹135.00 |
| Low | ₹132.00 | ₹132.00 |
| High | ₹140.65 | ₹141.75 |
| Last Trade | ₹140.65 | ₹141.75 |
Lead Manager Reports
Amanta Healthcare IPO is a main-board IPO of 1,00,00,000 equity shares of the face value of ₹10 aggregating up to ₹126 Crores. The issue is priced at ₹126 per share. The minimum order quantity is 119.
The IPO opens on Mon, Sep 1, 2025, and closes on Wed, Sep 3, 2025.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Amanta Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Amanta Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Amanta Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Amanta Healthcare IPO opens on Mon, Sep 1, 2025 and closes on Wed, Sep 3, 2025.
Amanta Healthcare IPO lot size is 119, and the minimum amount required for application is ₹14,994.
You can apply in Amanta Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Amanta Healthcare IPO will be done on Thursday, September 4, 2025, and the allotted shares will be credited to your demat account by Mon, Sep 8, 2025. Check the Amanta Healthcare IPO allotment status.
The Amanta Healthcare IPO listing date is on Tue, Sep 9, 2025.
